CAS: 190906-91-3; Benzyl 2-Methyl-4-Oxo-3,4-Dihydropyridine-1(2H)-Carboxylate

该化合物是属于二丙烯衍生物一类的化学化合物,该物质一般呈现黄色到褐色色,其特点是独特的双环结构,包括一个与碳基和酯功能组结合的环,苯基集团的存在会加强其脂性,有可能影响其溶解性和再活性.该化合物可能展示生物活动,使其对药用化学感兴趣,特别是药物的开发.其分子结构表明它有可能在各种化学反应中应用,包括涉及核本类替代或循环过程.与许多有机化合物一样,处理应该谨慎,考虑避免接触或不良反应的安全议定书.可能需要进一步研究,以充分阐明其在各个领域的特性和潜在应用,包括药物开发和合成化学.

结构式图片

相似化合物

185847-84-1 362704-44-7 919366-32-8

上下游产品

4-methoxypyridine methylmagnesium bromide benzyl chloroformate methylmagnesium chlorideH-pyridine-1-carboxylic acid benzyl ester3-(hydroxy-pyridin-4-yl-methyl)-2-methyl-4-oxo-3,4-dihydro-2H-pyridine-1-carboxylic acid benzyl ester H-pyridine-1-carboxylic acid benzyl ester3-[(2-chloro-phenyl)-hydroxy-methyl]-2-methyl-4-oxo-3,4-dihydro-2H-pyridine-1-carboxylic acid benzyl ester H-pyridine-1-carboxylic acid benzyl ester3-(hydroxy-phenyl-methyl)-2-methyl-4-oxo-3,4-dihydro-2H-pyridine-1-carboxylic acid benzyl ester H-pyridine-1-carboxylic acid benzyl ester3-(1-hydroxy-butyl)-2-methyl-4-oxo-3,4-dihydro-2H-pyridine-1-carboxylic acid benzyl ester

合成工艺路线路线简述

    📜在 盐酸,水体系中,用 乙醚 用作溶剂,以4.12 G的收率获得3,4-二氢-2-甲基-4-氧代吡啶-1(2H)-甲酸苄酯
    参考文献:Stereoselective Synthesis Of 4-Amino-2,3-Unsaturated-N-Cbz-Imino-O-Glycosides Via New Diastereoisomeric N-Cbz-Imino Glycal-Derived Allyl N-Nosyl Aziridines
    标题:Stereoselective Synthesis Of 4-Amino-2,3-Unsaturated-N-Cbz-Imino-O-Glycosides Via New Diastereoisomeric N-Cbz-Imino Glycal-Derived Allyl N-Nosyl Aziridines
    摘要:The Glycosylation Of Alcohols By The New Diastereoisomeric D,L-6-Deoxy-N-Cbz-Imino Glycal-Derived Allyl N-Nosyl Aziridines 5 And 6 Affords,After Deprotection Of The 4-(N-Nosylamino) Group,The Corresponding 2,3-Unsaturated-N-Cbz-Imino-O-Glycosides Bearing A Free Amino Group On C(4) Through A Completely 1,4-Regio-And Substrate-Dependent Stereoselective Glycosylation Process.
    Doi:10.1021/ol900742P

    海关参考信息

    专利信息


    专利号:WO-2012172449-A1
    优先权日:2011-06-13
    标题:Lactams as beta secretase inhibitors
    发明人:BRODNEY MICHAEL AARON
    权利人:PFIZER; BRODNEY MICHAEL AARON
    摘要:Compound and pharmaceutically acceptable salts of the compound are disclosed, wherein the compound has the structure (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed. The compound of formula I is useful as beta secretase inhibitor for use in the treatment of Alzheimer's and other neurodegenerative and/or neurological disorders.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知